1. Home
  2. ALLK vs FNWD Comparison

ALLK vs FNWD Comparison

Compare ALLK & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • FNWD
  • Stock Information
  • Founded
  • ALLK 2012
  • FNWD 1994
  • Country
  • ALLK United States
  • FNWD United States
  • Employees
  • ALLK N/A
  • FNWD N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • FNWD Savings Institutions
  • Sector
  • ALLK Health Care
  • FNWD Finance
  • Exchange
  • ALLK Nasdaq
  • FNWD Nasdaq
  • Market Cap
  • ALLK 101.0M
  • FNWD 117.3M
  • IPO Year
  • ALLK 2018
  • FNWD N/A
  • Fundamental
  • Price
  • ALLK $0.86
  • FNWD $27.01
  • Analyst Decision
  • ALLK Hold
  • FNWD
  • Analyst Count
  • ALLK 4
  • FNWD 0
  • Target Price
  • ALLK $1.67
  • FNWD N/A
  • AVG Volume (30 Days)
  • ALLK 827.7K
  • FNWD 3.2K
  • Earning Date
  • ALLK 03-13-2025
  • FNWD 01-28-2025
  • Dividend Yield
  • ALLK N/A
  • FNWD 1.78%
  • EPS Growth
  • ALLK N/A
  • FNWD 7.22
  • EPS
  • ALLK N/A
  • FNWD 2.71
  • Revenue
  • ALLK N/A
  • FNWD $69,627,000.00
  • Revenue This Year
  • ALLK N/A
  • FNWD N/A
  • Revenue Next Year
  • ALLK N/A
  • FNWD $1.04
  • P/E Ratio
  • ALLK N/A
  • FNWD $9.97
  • Revenue Growth
  • ALLK N/A
  • FNWD 3.96
  • 52 Week Low
  • ALLK $0.54
  • FNWD $22.82
  • 52 Week High
  • ALLK $1.69
  • FNWD $33.50
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 35.16
  • FNWD 32.47
  • Support Level
  • ALLK $0.81
  • FNWD $27.02
  • Resistance Level
  • ALLK $1.00
  • FNWD $27.81
  • Average True Range (ATR)
  • ALLK 0.13
  • FNWD 0.52
  • MACD
  • ALLK -0.03
  • FNWD -0.10
  • Stochastic Oscillator
  • ALLK 8.43
  • FNWD 3.68

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

Share on Social Networks: